| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 15/09/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 180 | 0 | 0 | 0 | 0 | 180 |
| 15/09/2021 | CORONAVAC | Butantan/CoronaVac | 0 | 190 | 0 | 0 | 0 | 190 |
| 17/09/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 504 | 0 | 0 | 0 | 0 | 504 |
| 21/09/2021 | ASTRAZENECA | Fiocruz/Oxford/AstraZeneca | 0 | 100 | 0 | 0 | 0 | 100 |
| 21/09/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 156 | 0 | 0 | 0 | 156 |
| 21/09/2021 | CORONAVAC | Butantan/CoronaVac | 270 | 340 | 0 | 0 | 0 | 610 |
| 24/09/2021 | ASTRAZENECA | Fiocruz/Oxford/AstraZeneca | 0 | 270 | 0 | 0 | 0 | 270 |
| 24/09/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 498 | 0 | 0 | 0 | 498 |
| 24/09/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 36 |
| 27/09/2021 | ASTRAZENECA | Fiocruz/Oxford/AstraZeneca | 0 | 135 | 0 | 0 | 0 | 135 |
| 27/09/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 186 | 264 | 0 | 0 | 0 | 450 |
| 29/09/2021 | CORONAVAC | Butantan/CoronaVac | 160 | 0 | 0 | 0 | 0 | 160 |
| 29/09/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 162 | 0 | 0 | 0 | 0 | 162 |
| 01/10/2021 | ASTRAZENECA | Fiocruz/Oxford/AstraZeneca | 0 | 100 | 0 | 0 | 0 | 100 |
| 01/10/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 390 | 0 | 0 | 0 | 390 |
| 01/10/2021 | CORONAVAC | Butantan/CoronaVac | 0 | 10 | 0 | 0 | 0 | 10 |
| 04/10/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 138 | 0 | 0 | 0 | 138 |
| 04/10/2021 | ASTRAZENECA | Fiocruz/Oxford/AstraZeneca | 0 | 275 | 0 | 0 | 0 | 275 |
| 04/10/2021 | CORONAVAC | Butantan/CoronaVac | 0 | 130 | 0 | 0 | 0 | 130 |
| 08/10/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 318 | 0 | 0 | 0 | 318 |
| 08/10/2021 | CORONAVAC | Butantan/CoronaVac | 0 | 80 | 0 | 0 | 0 | 80 |
| 08/10/2021 | ASTRAZENECA | Fiocruz/Oxford/AstraZeneca | 0 | 95 | 0 | 0 | 0 | 95 |
| 08/10/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 444 |
| 18/10/2021 | ASTRAZENECA | Fiocruz/Oxford/AstraZeneca | 0 | 410 | 0 | 0 | 0 | 410 |
| 18/10/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 456 | 0 | 0 | 0 | 456 |
| 18/10/2021 | CORONAVAC | Butantan/CoronaVac | 0 | 280 | 0 | 0 | 0 | 280 |
| 18/10/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 114 | 0 | 0 | 0 | 0 | 114 |
| 18/10/2021 | CORONAVAC | Butantan/CoronaVac | 0 | 160 | 0 | 0 | 0 | 160 |
| 22/10/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 264 | 168 | 0 | 0 | 0 | 432 |
| 27/10/2021 | PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 510 | 0 | 0 | 0 | 510 |
